ShotLog – GLP-1 Tracker
ShotLog is a health-tracking app for GLP-1 medication users on iOS that logs injections, symptoms, and weight progress.
The App DNA
What makes this app unique?
The app removes the manual friction of tracking complex, long-term medication schedules and side-effect patterns, which is a primary pain point for patients on GLP-1 therapies.
For Individuals prescribed GLP-1 medications (Ozempic, Wegovy, Mounjaro, Zepbound) requiring structured health and dosage tracking.
What does it look like?
Key features
Logs injection dates, dosage amounts, and site locations for specific GLP-1 medications.
Conversational interface for logging activities and receiving personalized health guidance.
Records side effects, meal intake, and hydration levels to identify patterns.
How much does it cost?
Utilizes Apple App Store billing with auto-renewing subscriptions to monetize advanced analytics.
Velocity
Dormant developmentnew contentUX improvementsShow more...
With only one release in the observed window and no updates for 203 days, the app is currently in a zombie state. Development momentum has stalled completely, as no new features or maintenance patches have been deployed since the introduction of the AI Coach in the latest version. The lack of activity over the past seven months suggests the project is no longer receiving active support.
Who built it?
YILDIZCO YAZILIM IC VE DIS TICARET LIMITED SIRKETI
5 apps tracked · Health & Fitness
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for ShotLog – GLP-1 Tracker
How's the Health & Fitness market?
ShotLog holds a 4.5-star rating across 45 reviews on the iOS platform. The lack of recent updates over the last six months suggests a stable but stagnant market position compared to more frequently iterated health-tracking tools.
The rivals identified
The Analyst's Read
Key takeaways for ShotLog – GLP-1 Tracker
Where is it heading?
The GLP-1 tracking market is shifting toward automated, interactive health guidance. ShotLog is currently exposed due to its stagnant release cadence, which limits its ability to respond to user feedback or integrate with emerging wearable data trends.
- The 6-month update gap suggests a lack of active feature investment, which may lead to user churn as competitors iterate faster.
- The AI Coach integration provides a unique conversational interface that differentiates ShotLog from static, manual-entry health trackers.
The SWOT
- Minimalist interface reduces cognitive load for chronic medication logging
- Wearable data integration could automate manual symptom logging
Next best moves
Audit AI Coach engagement because the 6-month update gap suggests potential abandonment → inform future development roadmap
The counter-intuitive read
The 6-month update silence is not necessarily a failure…
Read the full takeBottom line
The AI Coach integration provides a path to higher retention, but the current development silence risks losing the competitive edge to more active health-tracking platforms. Validating user engagement with the latest features would clarify whether to pivot or sunset the current roadmap.
Unlock 1 critical friction, 1 market threat and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated